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Objectives: Identify fall prevalence in the last 12 months among patients with rheumatoid
arthritis (RA) and verify the inﬂuence of disease activity and physical function in the risk of
falls.
Methods: 43 patients with RA participated in this study. The following parameters were eval-
uated: clinical aspects; fall occurrence in the last 12 months; ESR (mm/h); pain on a visual
analogue scale (VAS) ranging from 0 to 10 cm; disease activity, measured by the Disease
Activity Score 28/ESR (DAS-28/ESR); physical function, assessed by the Health Assessment
Questionnaire (HAQ); and risk of falling, assessed by two tests, the 5-time sit down-to-stand
up  test (SST5) and the get up and go timed test (GUGT).
Results: The fall prevalence in the last 12 months was 30.2% (13/43). The HAQ total score
was  the independent risk factor that had signiﬁcant inﬂuence on SST5 performance, and
the  other variables did not succeeded to explain the SST5 variability. HAQ explained 42.9%
of  SST5 variability (P < 0.001, adjusted R2 = 0.429). HAQ total score and ESR had a signiﬁcant
inﬂuence on GUGT score performance. Together, these two variables explained 68.8% of the
total variation in GUGT score (adjusted R2 = 0.688).
Conclusion: Patients with RA have high fall prevalence and the functional disability repre-
sents the main factor related to falls risk.
© 2014 Elsevier Editora Ltda. All rights reserved.
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Objetivos: Identiﬁcar a prevalência de quedas nos últimos 12 meses em pacientes com artrite
reumatoide (AR) e veriﬁcar a inﬂuência da atividade da doenc¸a e da capacidade funcional
no  risco de quedas.
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Capacidade funcional
Atividade da doenc¸a
Pacientes e métodos: Participaram do estudo 43 pacientes com AR. Foram avaliados os
seguintes parâmetros: aspectos clínicos; ocorrência de quedas nos últimos 12 meses; VHS
(mm/h); dor, através da escala visual analógica (EVA) com escore de 0 a 10 cm; atividade da
doenc¸a, medida pelo Índice de Atividade da Doenc¸a – 28/VHS (Disease Activity Score 28 – DAS-
28/VHS); capacidade funcional, avaliada pelo Questionário de Avaliac¸ão da Saúde (Health
Assessment Questionnaire – HAQ); e o risco de quedas, avaliado por meio de dois testes, o
teste senta-levanta da cadeira cinco vezes (TSL) e o teste get up and go timed test (GUGT).
Resultados: A prevalência de quedas nos últimos 12 meses foi de 30,2% (13/43). O fator
independente que inﬂuenciou signiﬁcativamente o desempenho no TSL foi o escore total
do  HAQ, sendo que as demais variáveis não conseguiram contribuir de forma signiﬁcativa
na  explicac¸ão da variabilidade no TSL. A variável HAQ foi responsável por explicar 42,9%
(P  < 0,001, R2 ajustado = 0,429) da variabilidade do TSL. As variáveis HAQ e VHS inﬂuenciaram
de  forma signiﬁcativa o desempenho no escore do GUGT. Esses dois fatores em conjunto
foram capazes de explicar 68,8% da variabilidade do GUGT (R2 ajustado = 0,688).
Conclusões: Pacientes com AR têm prevalência de quedas aumentada, sendo a incapacidade
funcional o principal fator relacionado ao risco de quedas.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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atients with rheumatoid arthritis (RA) are in increased risk
f falls, as they often experience muscle weakness, joint pain
r stiffness and disorders of balance and gait. The risk of
alling is even greater when there is involvement of the lower
xtremities.1–3
Studies in this population demonstrate an increased rate
f falls, from 27-50% over a year of research.3–7 However, due
o shortage of papers on this subject, the prevalence of falls
ay be underestimated.1
Falls are the leading cause of accidental death in people
ver 65 years old.8 Approximately 40-60% of falls among the
lderly lead to some kind of injury. Of the total injuries, 30 to
0% are considered of minor severity, 5-6% are considered as
ore serious injuries and 5% result in fractures.8–10
Few studies involving patients with RA have focused on
he evaluation of falls, despite being considered a population
t risk.1
Thus, the purpose of this study was to identify the preva-
ence of falls in a period of 12 months, in addition to verifying
he inﬂuence of disease activity and of functionality in the risk
f falls in patients with rheumatoid arthritis.
atients  and  methods
atients  and  Procedures
his study has a cross-sectional design.
Patients in our referral center with a diagnosis of RA accord-
ng to American College of Rheumatology criteria (ACR, 1987)11
ere included after signing the free informed consent term.
he study was approved by the local Research Ethics Commit-
ee (Protocol No. 013/2012).
Exclusion criteria were: age under 30 years; hospitalization
ue to acute illness in the previous six months from the inter-
iew; and presence of any temporary disability preventing theparticipant from performing the mobility tests. The subjects
were ﬁrst asked to answer a questionnaire about: (1) identiﬁca-
tion data; (2) duration of illness; (3) presence of comorbidities;
(4) use of a gait supportive gear; (5) history of arthroplasty;
(6) history of falls in the past 12 months; (7) occurrence of
fractures secondary to falls; (8) lifestyle; and (9) current med-
ications.
To evaluate the activity of RA, the following variables were
used: ESR (mm/h); pain using a visual analog scale (VAS) with
a score of 0 to 10 cm;  and Index of Disease Activity-28/ESR
(Disease Activity Score 28 - DAS-28/ESR).12
The assessment of functional capacity of patients was esti-
mated by the Health Assessment Questionnaire - HAQ.
To assess the risk of falls and the mobility of patients, two
tests were performed: (1) 5-time sit down-to-stand up test
(SST5) and (2) get up and go timed test (GUGT).
The 5-time sit down-to-stand up test (SST5) is used to
assess the muscle strength of lower limbs, mobility and risk of
falls.13,14 In this test, the subject begins sitting on the center
of a chair with his/her spine erect, feet separated by a distance
equivalent to the distance between the shoulders, and arms
folded across the thorax. Then the patient is asked to stand
up and sit down on the chair ﬁve times as quickly as he/she
can, without using his/her arms.13
The get up and go timed test (GUGT) is used to identify
patients at risk of falls and for mobility restrictions.8,15 In this
test, the subject begins in a seated position with his back
against the backrest of the chair, being asked to stand up
(his/her arms can be used), walk for a distance of three meters
in his/her usual gait speed, turn around, return to the chair
and sit in the start position.15
The time spent to complete SST5 and GUGT tests is timed,
and the longer the time, the worse the mobility of the subject.Statistical  analysis
It was performed a regression analysis via Quasi-Likelihood
method with variance function proportional to the mean and
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Table 1 – Patients’ characteristics.
Characteristic Value
Patients, n 43
Women, n (%) 37 (86.0%)
Positivity for rheumatoid factor, n (%) 26 (60.5%)
Age (years), mean ± SD (min-max) 58.7 ± 9.1 (43-80)
Self-reported color, n (%)
White 18 (41.9%)
Black 8 (18.6%)
Mixed (brown) 17 (39.5%)
Disease duration (years), mean ± SD (min-max) 12.2 ± 9.1 (1-30)
Use of a gait supportive gear, n (%) 8  (18.6%)
Presence of arthroplasty (knee and/or hip), n (%) 3 (7.0%)
HAQ, mean ± SD (min-max) 1.15 ± 0.78 (0-3)
DAS-28, mean ± SD (min-max) 4.01 ± 1.31 (0.8-6.8)
ESR (mm/h), mean ± SD (min-max) 29.86  ± 22.11 (3-118)
Pain by VAS (cm), mean ± SD (min-max) 4.74 ± 2.52 (0-10)
SST5 (seconds), mean ± SD (min-max) 15.07 ± 5.81 (8.3-25)
GUGT (seconds), mean ± SD (min-max) 17.40 ± 11.61 (9.2-60)
Smokers or ex-smokers, n (%) 24 (55.8%)
Practicing physical activity n (%) 6 (14.0%)
SD, standard deviation; HAQ, Health Assessment Questionnaire;
DAS-28, Disease Activity Index- 28; ESR, erythrocyte sedimenta-
tion rate; VAS, visual analog scale used to assess pain; SST5, 5-time
sit-to-stand test; GUGT, get up and go timed test.
a logarithmic link function in order to verify the inﬂuence of
disease activity, functional capacity and other variables on the
risk of falls.
In the multivariate regression ﬁnal analysis, the Stepwise
selection algorithm was used, referred to as Stepwise log-
linear regression.
The level of signiﬁcance was set at 5%. The statistical anal-
ysis was performed using R software version 2.15.3.
Results
Patients
According to exclusion criteria, one patient with limitation
due to a fall was excluded because of a recent foot fracture
that made it impossible to walk.
Forty-three patients participated in the study. Table 1 lists
the characteristics of this population.
As for medications, the major pharmacological classes
used in these patients were: disease-modifying anti-
rheumatic drugs (DMARDs) (95.3%); calcium carbonate
supplementation with vitamin D3 (88.4%); corticosteroids
(74.4%); gastric protectors (74.4%); bisphosphonates (53.5%);
antihypertensive drugs (46.5%); nonsteroidal anti- inﬂam-
matory drugs (44.2%); and lipid-lowering drugs (37.2%). Ten
patients (23.2%) were using central action drugs, as follows:
8 were taking antidepressants; 1 was on antidepressant and
benzodiazepine therapy; and 1 was medicated with an anti-
convulsant drug. And eight patients (18.6%) used biological
agents for control of the disease.
Each patient presented a mean of 4 ± 2.1 comorbidities,
ranging from 0 to 9. The four most prevalent comorbidities in
this study were: osteoporosis (55.8%), secondary osteoarthritis
(53.5%), hypertension (51.2%) and dyslipidemia (41.9%). 0 1 4;5 4(5):404–408
Falls  and  fractures  secondary  to  falls
At the time of the interview, 13 patients (30.2%) reported at
least one episode of falling in the past 12 months.
Among the 13 patients who had suffered falls, only one
reported a fracture secondary to fall (7.7%).
Five patients (11.6%) reported post-fall fractures that
occurred earlier to the 12-month period of our analysis.
Analysis  of  the  inﬂuence  of  disease  activity  and  functional
capacity  on  the  risk  of  falls
Table 2 shows the results of analyses of a univariate log-linear
regression of the factors associated to the risk of falls, evalu-
ated by SST5 and GUGT tests.
In the univariate model, a signiﬁcant association was
observed between risk of falls, rated by SST5, and the following
variables: age (P = 0.052; R2 = 0.070), disease duration (P = 0.045,
R2 = 0.075), ESR (P = 0.032; R2 = 0.083), number of comorbidi-
ties (P = 0.041, R2 = 0.078) and HAQ score (P < 0.001, R2 = 0.429)
(Table 2).
Also in the univariate model, a signiﬁcant association
was observed between the risk of falls, rated by GUGT, and
the following variables: ESR (P = 0.001; R2 = 0.250), presence
of arthroplasty (P = 0.038, R2 = 0.083) and HAQ score (P < 0.001,
R2 = 0.665) (Table 2).
In the ﬁnal model of Stepwise log-linear regression with
respect to the performance in SST5, only the HAQ variable was
signiﬁcant, and succeed to explain 42.9% of SST5 variability
(R2 = 0.429) (Table 3).
As to the performance of subjects in GUGT, in the multi-
variate model the variables HAQ and ESR were signiﬁcant in
explaining, together, 68.8% of the variability of GUGT (adjusted
R2 = 0.688) (Table 3).
Discussion
This study identiﬁed the prevalence of falls in the past
12 months and evaluated the inﬂuence of disease activity and
functional capacity in the risk of falls in adults with RA.
In this study, a prevalence of falls of 30.2%, similar to retro-
spective studies, has been found.3–5 Functional disability was
the main factor associated with risk of falls in this population.
Previous studies show different frequencies of falls in
patients with RA. In retrospective studies, the occurrence of
falls in patients with RA over a period of 12 months was
27%,4 33%3 and 35%.5 In prospective studies, the incidence of
falls in 12 months ranged from 36.4%6 to 50%.7
In this study, patients were inquired about the occurrence
of falls in the past 12 months; thus, following a retrospective
design. The literature demonstrates that retrospective stud-
ies may underestimate the prevalence of falls, since patients
tend to forget progressively these episodes.16 This factor con-
stitutes a limitation, and may underestimate the prevalence
of falls observed in our sample.
Regarding factors associated with risk of falls in patients
with RA, the functional disability measured by HAQ total score
was the primary factor found in this study.
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Table 2 – Result of the association among risk of fall (SST5 and GUGT) and evaluation parameters of disease activity (ESR,
VAS and DAS-28) and functional capacity (HAQ).
Variable SST5 GUGT
exp () P-value 95% CI R2 exp () P-value 95% CI R2
Age (years) 1.012 0.052 [1.000 - 1.025] 0.070 1.017 0.116 [0.996 - 1.038] 0.046
Disease duration (years) 1.013 0.045 [1.001 - 1.025] 0.075 1.012 0.305 [0.990 - 1.034] 0.002
ESR (mm/h) 1.005 0.032 [1.001 - 1.01] 0.083 1.012 0.001 [1.005 - 1.018] 0.250
Pain by VAS (cm) 1.021 0.398 [0.974 - 1.069] 0.000 1.015 0.729 [0.935 - 1.101] 0.000
Number of comorbidities 1.058 0.041 [1.004 - 1.115] 0.078 1.095 0.06 [0.999 - 1.199] 0.079
Presence of arthroplasty 1.158 0.506 [0.755 - 1.777] 0.000 1.859 0.038 [1.056 - 3.273] 0.083
Positive rheumatoid factor 0.932 0.561 [0.736 - 1.18] 0.000 0.889 0.574 [0.592 - 1.335] 0.000
DAS-28 1.06 0.215 [0.968 - 1.159] 0.015 1.11 0.185 [0.954 - 1.292] 0.025
HAQ 1.365 < 0.001 [1.227 - 1.518] 0.429 1.796 < 0.001 [1.585 - 2.035] 0.665
Univariate log-linear regressions.
ESR, erythrocyte sedimentation rate; VAS, visual analog scale used to assess pain; DAS-28, Disease Activity Index- 28; HAQ, Health Assessment
Questionnaire; SST5, 5-time sit-to-stand test; GUGT, get up and go timed test.
Table 3 – Inﬂuence of functional capacity (HAQ) and ESR on the risk of falls, evaluated by SST5 and GUGT tests.
Variable SST5 GUGT
exp () P-value 95% CI Adjusted R2 exp () P-value 95% CI Adjusted R2
HAQ 1.365 <0.001 [1.227–1.518] 0.429 1.684 <0.001 [1.471–1.928] 0.688
ESR (mm/h) - - - - 1.004 0.0477 [1.001–1.008]
Stepwise log-linear multivariate regression.
tion r
m
t
I
o
i
a
G
h
a
a
T
a
f
R
w
t
d
o
p
i
d
r
m
h
oHAQ, Health Assessment Questionnaire; ESR, erythrocyte sedimenta
Böhler et al.4 found a correlation among the tests for assess-
ent of the risk of falls, among them SST5 and GUGT, with
he following variables: HAQ, DAS- 28, pain by VAS, and ESR.
n the speciﬁc case of ESR, these authors found a correlation
nly with GUGT and not with SST5. Similar to our study ﬁnd-
ngs, HAQ inﬂuenced the performance of both tests used to
ssess the risk of falls; on the other hand, ESR only acted on
UGT.
Duyurc¸akit et al.17 found a positive association between
istory of falls and performance on the Tinetti test used to
ssess the risk of falls. These authors also observed an associ-
tion between fear of falling and Tinetti and HAQ ﬁnal scores.
he authors found no association between disease activity
nd the risk of falls.
The inﬂuence of functional disability in the risk of falls, as
ound in our study, was an expected ﬁnding. In patients with
A, other authors found an association of high HAQ scores
ith joint destruction and with decreased muscle strength,
he latter being considered as risk factor for falls.18–20
In the present study, no association was found between
isease activity, as assessed by DAS- 28, and an increased risk
f falls. However, an association between the value of ESR and
erformance on GUGT test was found.
Due to the existing limitations in counting the joints used
n DAS-28, some authors recommend adding other forms of
isease activity assessment, such as laboratory tests, self-
eported measures in questionnaires, and global estimates
21ade by doctors and patients.
With regard to associated factors of risk of falls, this study
as some limitations. Most patients showed a moderate level
f disease activity, calculated by DAS- 28, which, together withate; SST5, 5-time sit-to-stand test; GUGT, get up and go timed test.
the sample size, may have some inﬂuence in the lack of asso-
ciation between DAS- 28 and the risk of falls. Furthermore, the
inﬂuence of other factors on the risk of falls, such as the use
of certain classes of drugs (antihypertensive drugs, diuretics,
antidepressants and sedatives) was not analyzed.
In our study, the age limit of 30 years was established, since
the peak incidence of RA occurs between the fourth and sixth
decades of life. It is worth to mention that the prevalence of
RA increases with age; and the literature points to an increas-
ingly aging proﬁle of patients with RA.22 The mean age of our
sample was 58.7 ± 9.1 years.
We also observed that osteoporosis was the most prevalent
comorbidity (55.8%). Osteoporosis is associated with frac-
ture risk.23 Studies evaluating injuries from falls show that
hip, wrist, vertebrae, humerus and hand fractures are mainly
caused by falls.24
The relevance of this study is to point out an increased
prevalence of falls in patients with RA. Moreover, our paper
draws attention to the impact of functional disability, mea-
sured by the HAQ score, on the risk of falls in this population.
In conclusion, patients with RA have an increased preva-
lence of falls, and functional disability is associated with the
risk of falls in these individuals.
RA patients should be monitored for functional capacity
and bone mass, aiming to prevent falls and consequently
to prevent fractures, contributing to a better prognosis of
rheumatic disease.Conﬂict  of  interests
The authors declare no conﬂicts of interest.
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